Initial work on the exocytotic machinery of predocked insulin secretory granules (SGs) in pancreatic β-cells mimicked the SNARE hypothesis work in neurons, which includes SM/SNARE complex and associated priming proteins, fusion clamps and Ca 2+ sensors. However, β-cell SGs, unlike neuronal synaptic vesicles, exhibit a biphasic secretory response that requires additional distinct features in exocytosis including newcomer SGs that undergo minimal docking time at the plasma membrane (PM) before fusion and multi-SG (compound) fusion. These exocytotic events are mediated by Munc18/SNARE complexes distinct from that which mediates predocked SG fusion. We review some recent insights in SNARE complex assembly and the promiscuity in SM/SNARE complex formation, whereby both contribute to conferring different insulin SG fusion kinetics. Some SNARE and associated proteins play non-fusion roles, including tethering SGs to Ca 2+ channels, SG recruitment from cell interior to PM, and inhibitory SNAREs that block the action of profusion SNAREs. We discuss new insights into how sub-PM cytoskeletal mesh gates SG access to the PM and the targeting of SG exocytosis to PM domains in functionally polarized β-cells within intact islets. These recent developments have major implications on devising clever SNARE replacement therapies that could restore the deficient insulin secretion in diabetic islet β-cells. We discuss each of these exciting developments.
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K E Y W O R D S
insulin secretion, newcomer granules, SNARE proteins For decades, much work has been done but remains vigorously pursued in revealing the elusive mechanisms of insulin secretion in the pancreatic β-cell. The collective goal has been to eventually identify new therapeutic strategies that can improve the deficient insulin secretion, sufficient to restore glucose homeostasis in patients afflicted by diabetes. We here focus on the most recent work on the insulin secretory granule (SG) exocytotic machinery of the β-cell. Previous work has elucidated the exocytotic machinery of predocked insulin SGs, which revolves around the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) hypothesis. 1, 2 The more recent work has been more directed at identifying the distinct set of SNARE and SNARE-associated proteins that mediate the exocytosis of newcomer insulin SGs. 3 In addition to SG fusion, new findings show that some of these proteins could also play non-membrane fusion roles in the insulin secretory process. Recent insights are revealing novel mechanisms on how the cytoskeletal mesh beneath the plasma membrane (PM) regulates the access of insulin SGs to the PM to sustain secretion. Some recent work showed that insulin SG exocytosis occurs at preferred sites of the β-cell PM within an intact islet. The latter indicates that the morphologically non-polarized β-cell actually exhibits functional polarity that mimics the neuronal synapse.
We discuss each of these exciting developments.
1 | SM/SNARE COMPLEX AND NEW INSIGHTS INTO THE SNARE COMPLEX
| SM/SNARE complex of the predocked SG
Initial work in the pancreatic β-cell insulin SG exocytosis closely mimicked those in neuron wherein both fields have been in hot pursuit in proving the tenets of the SNARE hypothesis. and newcomer SGs, respectively. 41 The effect of the Munc18b/Syn-1A,VAMP2,SNAP25 complex became more manifest in T2D β-cells in restoring the defective predocked SG fusion. 37 This suggests that Munc18b could replace the deficient Munc18a in T2D β-cells.
37
Remarkably, Munc18b in vivo rescue using an adenovirus infused into the pancreatic duct of T2D Goto-Kakizaki (GK) rats, whose islets are known to be deficient in SM/SNARE proteins, 27 resulted in the restoration of the deficient biphasic GSIS, which led to major improvement in glucose homeostasis. and PKA-activated Rab-3 interacting molecule-2 (RIM2a), 48 are the primary substrates of GLP-1 activation shown to mediate recruitment of newcomer SGs. Epac2a/Rap1 seems to prefer newcomer SG recruitment to the RRP that contributes to first-phase GSIS, whereas RIM2a preferred newcomer SG recruitment from the reserve pool that accounts for second-phase GSIS.
GLP-1 also stimulates PKA-dependent phosphorylation of SNAP25 accessory snapin 49 and syt-7, 9 GLP-1 therefore acts through a myriad of exocytotic substrates to potentiate GSIS. Priming proteins.
Munc13-1 also influences the priming of newcomer SGs, 50 in fact in a manner that was found to be more sensitive than predocked SGs. sensor for newcomer SGs as syt-7 could also bind Syn-3 in addition to Syn-1A. 10 Whether the other Ca 2+ sensors (Doc2, CAPS) and fusion clamps (complexin, tomosyn) discussed above for predocked SG fusion can also influence newcomer SG fusion requires further study.
| Unsettled questions about newcomer SGs
While the work discussed above shows that newcomer SGs have higher Ca 2+ sensitivity than predocked SGs, the major question remains as to why the priming of newcomer SGs is so rapid such that these SGs do not require any docking time on the PM before fusion.
More work will be needed to show how the newcomer SM/SNARE complex (Munc18b/Syn-3,SNAP25,VAMP8) presumably undergo rapid assembly during stimulation; and how such is influenced by the associated proteins, that is, syt-7, Munc13 and others.
A second major question is whether newcomer SGs and predocked SGs are separate populations of SGs. An intriguing possibility to dare advance as a hypothesis is that perhaps all SGs arrive at the PM as newcomers undergoing various stages of priming. 24, 25 At basal state, these primed newcomer SGs would not fuse with the PM but become "predocked" SGs, some of which may then undergo an as yet undefined "aging" process, 56 ,57 whereby some SNARE complex disassembly would occur. This may be the major mechanism by which predocked SGs undergo de-priming which results in loss of fusion competence. In T2D, perhaps this de-priming process becomes amplified into an almost total loss of fusion competence of predocked SGs that may be attributed at least in part to the severely reduced levels of SNARE and associated proteins known to mediate predocked SG fusion. 27, 28 
| INSULIN SG FUSION PORE
Some early work has begun to assess the insulin SG fusion pore opening kinetics. 59,61-64 Intuitively, there would be a delay in the emptying of the crystalline insulin cargo until after the fusion pore opening is sufficient large. 59, 61 However, contrary to previous thinking, much of the insulin cargo is emptied in a fast-release partially dissolved form within a few hundred milliseconds, 33 while a smaller amount is in the slow-release larger crystalline form that takes seconds to minutes to empty. 33 The fast-release form of insulin could also allow emptying of more insulin cargo between the small fusion pores of compound SG-SG fusions. 36, 40, 60 It has been postulated that up to 20% of SG fusions with the PM are of the "kiss-and-run" type whereby the fusion pore only partially opens and then reseals to recapture the SG intact. 62 This "aborted" opening is not without purpose (ie, little or no emptying of insulin) but can allow release of other SG cargo smaller than insulin such as ATP and neurotransmitters (GABA, serotonin), which are capable of asserting paracrine actions. 62 This kiss-and-run fusion is not restricted to SG-PM fusion but also occurs between SG-SG fusions as suggested by the small fusion pores between SGs observed by EM employing thin serial sectioning. 36 As there has been only limited work, this continues to raise many questions as to how the insulin SG fusion pore opening is regulated. 63 For example, how do predock and newcomer SG SNARE complexes and associated proteins (ie, syt-7) interact to induce the mixing of the SG/PM phospholipid bilayers to form the proteo-lipid fusion pore? Another question is how are fusion pore openings regulated to dilate (or not, as in "kiss-and-run") and become stabilized for more prolonged opening that is required to empty the larger insulin cargo? We should pursue these studies to reveal new insights into SG-SG and SG-PM fusion pore opening, which are of importance in diabetes as optimal SG fusion pore opening would allow more efficient and complete emptying of the insulin cargo.
| NON-FUSION FUNCTIONS OF SNARE PROTEINS
Much is known regarding the role of SNARE and associated proteins in the sequential "distal" steps of SG docking, priming and fusion as discussed above. However, less is known about the preceding "proximal" steps of SG tethering to the exocytotic site; and even less known regarding the recruitment or replenishment of SGs to the PM after stimulated depletion of releasable pools. SNARE and SNAREassociated proteins, traditionally believed to assert their actions on the "distal" steps of exocytosis, have recently been reported to play additional roles in secretion on the more "proximal" steps of SG replenishment and SG tethering. 68 presumably to influence fusion of predocked and newcomer SGs. In fact, newcomer SNARE Syn-3 was found to also bind β-cell L-and R-type VDCCs, 69 suggesting that these Syn-3 excitosomes could potentially mediate newcomer SG fusions in first-and second-phase GSIS. Sec5, a major component of the octamer exocyst complex, which serves to tether SGs loosely to the PM, 70 was shown to regulate newcomer SG secretion. 71 GTPase RalA, the major effector of the exocyst, 72 also function to tether insulin SGs to L-and R-type VDCCs by binding to their common α 2 δ-1 subunit rather than their distinct pore-forming α subunits 73 ; however, the latter could also modulate VDCC gating. 73 These actions of RalA would in turn also influence the fusion of predocked and newcomer SGs. Snapin was recently shown to also play a role in tethering insulin SGs to the PM during resting condition, which precedes SNAP25 recruitment to Syn-1A during stimulation. 74 
| SG tethering and docking onto

| SG recruitment to PM after stimulated depletion
While much is known about the most distal steps of insulin SG exocytotic fusion, little is known about the recruitment of SGs from the cell interior to the PM after stimulated depletion of releasable pools. This is particularly important for β-cell (and other endocrine cells) that exhibit sustained secretion over many hours. Syn-1A depletion resulted in reduced replenishment of insulin SGs to the PM after glucose stimulation. 41 This could in part explain why Syn-1A depletion also contributed to some reduction of newcomer SG fusion, which resulted in a mild reduction in second-phase GSIS. 41 This is in addition to Syn-1A's known actions on predocked SG that contributes to first-phase GSIS. 32 This was also the case with syt-7 depletion in human β-cells. 10 In fact, this role of syt-7 in the replenishment of SGs from the β-cell interior to the PM after glucose-stimulated emptying of releasable pools superseded its function on the predock and newcomer SG SNARE fusion complexes at the PM. 10 This syt-7 action on SG replenishment, shown to also occur in neurons, might be mediated by a SNARE-independent mechanism, perhaps involving calmodulin.
10,77
| Inhibitory SNAREs
Of the 4 syntaxins specialized for exocytosis (Syn-1, -3 and -4 discussed above), syntaxin-2 is the least understood until now. Syn-2 deletion in mice unexpectedly exhibited a paradoxically superior glucose homeostasis, resulting from an enhanced biphasic GSIS. 78 The increased GSIS was attributed mainly from an enhanced recruitment of the larger pool of newcomer SGs and to lesser extent the predocked SGs. Syn-2 depletion resulted in stimulation-induced increase in SM/SNARE complexes that mediate newcomer (Munc18b/Syn-3,-VAMP8,SNAP25) and predocked SG (Munc18a/Syn-1A,VAMP2, SNAP25) fusions. SNAP23 has long been thought to play a functionally redundant role to SNAP25. 79 A recent report showed that SNAP23 deletion in β-cells also paradoxically increased the fusion of predocked 80 and newcomer SGs (unpublished results, manuscript in preparation) by increasing the formation of corresponding SNARE complexes, including Munc18a/Syn-1A,SNAP25,VAMP2 80 and Munc18b/Syn-3,SNAP25,VAMP8 (manuscript in preparation).
This opposing action between SNAP25 and SNAP23 had also been suggested to occur in chromaffin cells. 81 These recent reports raise the intriguing possibility that Syn-2 and SNAP23 may act as inhibitory SNAREs 82 in some secretory cells that also contain profusion Syns and SNAP25. However, SNAP23 deletion in slow-secreting pancreatic acinar cells inhibited exocytosis, 80 suggesting that SNAP23 might instead act as a cell context-specific partial agonist. Regardless, a small molecule drug compound that binds and blocks SNAP23 actions 80 or β-cell SNAP23 depletion (manuscript in preparation)
potently increased GSIS. The latter work was shown in T2D GK rats that restored GSIS and improved glucose homeostasis in a manner superior to conventional treatment with sulfonylureas and these effects were sustained for several months. This suggests that antagonizing SNAP23 (or Syn-2) in β-cells could be a therapeutic strategy to treat T2D patients.
| ACTIN CYTOSKELETON GATE CONTROLLING THE AVAILABILITY OF INSULIN SGS TO ACCESS THE PM
The cortical actin cytoskeleton acts as a gate for regulated exocytosis of insulin SGs by restricting their mobility and access to the PM. Glucose stimulation induces remodelling of the actin cytoskeleton, with reorganization of the subcortical actin network, which enables insulin SGs to access the PM t-SNARE proteins. 83, 84 Actin remodelling affects the Syn-1A/SNAP25 complex 84 and also the Munc18c/Syn-4 complex 83 ; both believed to influence predominantly the predocked SG fusion. However, it is the second-phase GSIS that is more affected by actin cytoskeleton remodelling, 83, 85 suggesting that newcomer SGs and hence the newcomer SM/SNARE complexes are also probably affected; this requires further study. In support, newcomer SG fusion events were observed to be clustered at hotspots at the PM, and this spatial pattern of delivery of newcomer SGs to the PM surface disappears upon disruption of either actin or the microtubule network that caused the reduction in exocytosis. 64 Prolonged exposure of β-cells to high glucose (glucotoxicity) 84 or palmitate (lipotoxicity) 86 increased the density of cortical actin, which inhibited GSIS in part by preventing acute glucose-induced actin reorganization that resulted in reduction of SG fusion events. 84 Here, GLP-1 could partially restore GSIS by preferential actions on Epac2 signalling in first phase, and PKA signalling in second phase of insulin exocytosis, 84 both probably to affect newcomer SGs. 47, 48 Actin remodelling is regulated by many factors, so far including: (1) gelsolin 87 which increases actin depolymerization that increased GSIS;
(2) β-catenin and villin which remodel actin to influence insulin SG localization and/or fusion ability for exocytosis 88, 89 and (3) GTPase dynamin 2 whereby its deletion enhanced actin filaments and insulin SG recruitment and mobilization. 90 Although we are beginning to gain more knowledge about how the sub-PM cytoskeletal mesh gates the availability of SGs to the PM, we still have very little insight as to how SGs are recruited from deeper into the cell interior to the PM inspite of some recent reports discussed above, 10, 41 " SGs recruited to the PM are restricted from the PM by a sub-PM actin cytoskeleton mesh which gates the availability of SGs to reach the PM, and which can be manipulated to increase SG availability for exocytosis.
Most of the information on insulin SG exocytosis has been obtained from isolated single-cell studies from rodent models. However, physiologically, β-cells exist within the islet micro-organ, with structural and functional specializations that are not preserved in single-cell cultures. 91 In fact, exocytotic responses in β-cells within an islet are very different from that of an isolated β-cell. 92 The former was proposed in early studies that insulin SG exocytosis in this apparently morphologically non-polarized cell to be in fact functionally polarized whereby exocytosis was directed at preferred PM domains of the β-cell. 59,91 Furthermore, there are major differences in the secretory responses of β-cells within a rodent islet and a human islet that are in part attributed to the very different islet architecture and distribution of the different islet cell types. 93 Moreover, in a rodent islet, the majority of islet β-cells are coupled; but in a human islet, there are distinct clusters of tightly coupled adjacent β-cells with each cluster exhibiting synchronized bursts of exocytosis with periods mimicking in vivo pulsatile insulin secretion. 94 It was noted in that study 94 that secretory events become progressively localized to preferential release sites coinciding with a transition to second-phase GSIS. A more detailed and higher resolution study will be required to see whether these are the preferential sites that recruit newcomer SGs to fuse on as a mechanism of SG replenishment that sustains secondphase GSIS. This may also be the case with the stepwise sequential SG-to-SG fusion occurring at "preferential" PM fusion sites that was observed in the Munc18b-overexpression study. 36 Recent studies have just begun to reveal some molecularstructural insights that may start to explain this polarized secretion of β-cells to preferential PM fusion sites within an intact islet. In situ mapping of β-cells within mouse islets using pancreatic slices showed 3 distinct cell surface domains, 95 providing evidence that the β-cell should be considered as a polarized cell type. Most important is a basal PM domain that is in contact with the vasculature where most insulin SG exocytosis was targeted, which was enriched with liprin, piccolo and RIM. 95, 96 As these proteins are normally associated with neuronal presynaptic targeting, this β-cell domain is analogous to the neuronal "active zone", thus termed the "endocrine synapse". 95, 96 The other 2 domains are the apical PM domain defined by the locations of PAR-3 and ZO1 where adjacent β-cells project their primary cilia; and a lateral PM domain where GLUT2 is located, which is enriched with E-cadherin, scribble and Dlg. 95 Surprisingly, the locations of Syn-1A and SNAP25 are not polarized but rather distributed across the β-cell. 95 The latter supports the thinking that these tSNAREs regulate not only SG fusion at the polarized preferential PM sites, but would also regulate VDCCs and K + channels (Kv2.1 and K ATP ) distributed along the PM. 75 This structural organization and segregation of these key proteins on different PM domains are probably to have functional significance for β-cell secretory behaviour.
β-cells within intact T2D db/db mouse islets showed altered exocytotic responses during progression of prediabetes to diabetes, 97 suggesting that structural and exocytotic polarization of β-cells might be a factor that is probably also perturbed in disease.
Although the insulin SG fusion sites seemed preferably targeted to the islet vasculature to deliver the insulin cargo into the circulation, insulin SG exocytosis also occurs at non-vascular sites that are adjacent to non-β-cells. 59 This secretory architecture enables the release of insulin and perhaps more importantly, neurotransmitters, that have important paracrine and autocrine effects on adjacent islet cells. 62 More work is required to elucidate the signalling pathways that would selectively direct insulin SGs to these distinct exocytotic sites in the polarized β-cell. In diabetes, these SG-targeting signalling pathways and/or β-cell PM-targeting cues could have been perturbed to in part explain the dysregulation of paracrine and autocrine islet cell-cell interactions. Such perturbation could also contribute to the disordered coupling between adjacent β-cells that may be a basis for the high basal secretion and/or loss of pulsatile secretion in T2D. To rectify the latter in the T2D islet, which would reduce the basal insulin release and restore the synchronicity of secretion of clustered β-cells, 92, 94 and also rectify the perturbed intra-islet crosstalk, we will need to figure out how to correct these possible distortions in polarized exocytosis in the T2D β-cell. This would restore the ability of β-cells to reorchestrate the diabetic intra-islet milieu in a manner capable of responding in more exquisite precision to the varying and increasing glycemic demand of a diabetic or obese patient.
Intact islets have features distinct from dispersed single β-cells which profoundly affect insulin secretion, including PM domainspecific molecular cues that define functional polarity of β-cells, and coupling of adjacent β-cells into large clusters that promote synchronized exocytosis and pulsatile secretion. Increasing new insights are being revealed using high-resolution imaging of whole islet preparations. However, future studies may also require using preparations that genuinely preserve the native structure of the islet, 93, 94 including its neural and circulatory network that are intact within a fresh pancreatic slice 95, 98 ; and eventually with in vivo strategies such as implanting fluorophore-tagged islets into the anterior chamber of the eye that can be observed longitudinally for several months by 2-photon microscopy. 99 The latter model can be subjected to experimental manipulation of bona fide disease conditions (ie, high fat diet) to track disease progression; and also to monitor the therapeutic rescue acutely and chronically. These approaches will reveal even more exciting new insights not only into the in situ native regulation of β-cell function, but also diabetic cellular dysfunction and novel treatment strategies and responses that replicate the clinical conditions.
| CONCLUDING REMARKS
In this review, I have attempted to collate and discuss the most recent published work pertaining to β-cell exocytosis. There remain many gaps in our knowledge, some of which I have mentioned in each of the above sections, which require much further study. Perhaps the more important issue is whether we can translate these basic insights into treatment strategies for diabetes. One would be tempted to simply increase the amount of a deficient SNARE protein in T2D β-cells to drive more insulin SG fusions to restore the deficient biphasic GSIS. However, a slight excess of a SNARE protein such as Syn-1A, expressed genetically into mice, actually resulted in a paradoxical reduction in GSIS. 100 This is perhaps a result of stoichiometric mismatch with the formation of incomplete SNARE complexes that are not fusion-competent, and which can compete with fusion-competent complete SNARE complexes. On the other hand, restoring an SM protein such as Munc18b into islets by pancreatic ductal infusion of an adenovirus was able to partially rescue the insulin secretory deficiency in T2D GK rats. 37 This resulted in greatly improved glucose homeostasis in the GK rats that was maintained for several weeks. 37 The mechanism of rescue by the Munc18b overexpression was by driving cognate SNARE complex assembly of even the reduced levels of SNARE proteins of the T2D islets. 37 The Munc18b-driven SNARE complexes increased newcomer and compound SG fusions. 36 Increasing the efficiency of recruitment and/or priming of newcomer SGs 3 or induction of compound SG fusion 40, 58 could compensate for the deficiency in predocked SG fusion in the T2D β-cells. Another approach to improve exocytotic efficiency is to reduce the levels or antagonize the actions of inhibitory SNAREs (Syn-2, SNAP23), 78, 80 which would enable even the reduced levels of profusion SNARE proteins in T2D β-cells to more effectively promote insulin SG fusion. More work will be required to assess replacement strategies of other candidate exocytotic proteins into T2D islets. These and the other considerations discussed in this review have major implications on devising clever SNARE replacement therapies that could restore the deficient GSIS in T2D patients.
SNARE and associated proteins can serve non-fusion roles, including tethering SGs to Ca 2+ channels for exposure to maximal 
